Literature DB >> 17452607

Development of a ventilatory classification system in patients with heart failure.

Ross Arena1, Jonathan Myers, Joshua Abella, Mary Ann Peberdy, Daniel Bensimhon, Paul Chase, Marco Guazzi.   

Abstract

BACKGROUND: Ventilatory efficiency, commonly assessed by the minute ventilation (VE)-carbon dioxide production (VCO2) slope, is a powerful prognostic marker in the heart failure population. The purpose of the present study is to refine the prognostic power of the VE/VCO2 slope by developing a ventilatory class system that correlates VE/VCO2 cut points to cardiac-related events. METHODS AND
RESULTS: Four hundred forty-eight subjects diagnosed with heart failure were included in this analysis. The VE/VCO2 slope was determined via cardiopulmonary exercise testing. Subjects were tracked for major cardiac events (mortality, transplantation, or left ventricular assist device implantation) for 2 years after cardiopulmonary exercise testing. There were 81 cardiac-related events (64 deaths, 10 heart transplants, and 7 left ventricular assist device implantations) during the 2-year tracking period. Receiver operating characteristic curve analysis revealed the overall VE/VCO2 slope classification scheme was significant (area under the curve: 0.78 [95% CI, 0.73 to 0.83], P<0.001). On the basis of test sensitivity and specificity, the following ventilatory class system was developed: (1) ventilatory class (VC) I: < or = 29; (2) VC II: 30.0 to 35.9; (3) VC III: 36.0 to 44.9; and (4) VC IV: > or = 45.0. The numbers of subjects in VCs I through IV were 144, 149, 112, and 43, respectively. Kaplan-Meier analysis revealed event-free survival for subjects in VC I, II, III, and IV was 97.2%, 85.2%, 72.3%, and 44.2%, respectively (log-rank 86.8; P<0.001).
CONCLUSIONS: A multiple-level classificatory system based on exercise VE/VCO2 slope stratifies the burden of risk for the entire spectrum of heart failure severity. Application of this classification is therefore proposed to improve clinical decision making in heart failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452607     DOI: 10.1161/CIRCULATIONAHA.107.686576

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  66 in total

Review 1.  Cardiopulmonary exercise test in chronic heart failure: beyond peak oxygen consumption.

Authors:  Veronica Franco
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 2.  Pulmonary hypertension with left-sided heart disease.

Authors:  Marco Guazzi; Ross Arena
Journal:  Nat Rev Cardiol       Date:  2010-10-05       Impact factor: 32.419

Review 3.  Testosterone and heart failure.

Authors:  Maurizio Volterrani; Giuseppe Rosano; Ferdinando Iellamo
Journal:  Endocrine       Date:  2012-06-24       Impact factor: 3.633

4.  Prognostic value of capnography during rest and exercise in patients with heart failure.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Paul Chase; Daniel Bensimhon; Lawrence P Cahalin; Mary Ann Peberdy; Euan Ashley; Erin West; Daniel E Forman
Journal:  Congest Heart Fail       Date:  2012-04-26

Review 5.  The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review.

Authors:  Ross Arena; Jonathan Myers; Marco Guazzi
Journal:  Heart Fail Rev       Date:  2007-11-07       Impact factor: 4.214

6.  Cardiopulmonary exercise testing in heart failure: from ugly duckling to swan.

Authors:  Damiano Magrì; Massimo Volpe
Journal:  Intern Emerg Med       Date:  2009-03-04       Impact factor: 3.397

Review 7.  Abnormalities in cardiopulmonary exercise testing ventilatory parameters in heart failure: pathophysiology and clinical usefulness.

Authors:  Marco Guazzi
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 8.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

9.  Prognostic value of brain natriuretic peptide and enhanced ventilatory response to exercise in patients with chronic heart failure.

Authors:  Angela Beatrice Scardovi; Renata De Maria; Andrea Celestini; Claudio Coletta; Nadia Aspromonte; Silvia Perna; Marina Parolini; Roberto Ricci
Journal:  Intern Emerg Med       Date:  2008-06-17       Impact factor: 3.397

10.  Assessment of the effects of physical training in patients with chronic heart failure: the utility of effort-independent exercise variables.

Authors:  Hareld M C Kemps; Wouter R de Vries; Sandor L Schmikli; Maria L Zonderland; Adwin R Hoogeveen; Eric J M Thijssen; Goof Schep
Journal:  Eur J Appl Physiol       Date:  2009-10-16       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.